BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35447986)

  • 1. SARS-CoV-2, COVID-19 and Parkinson's Disease-Many Issues Need to Be Clarified-A Critical Review.
    Goerttler T; Kwon EH; Fleischer M; Stettner M; Tönges L; Klebe S
    Brain Sci; 2022 Mar; 12(4):. PubMed ID: 35447986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism.
    Leta V; Boura I; van Wamelen DJ; Rodriguez-Violante M; Antonini A; Chaudhuri KR
    Int Rev Neurobiol; 2022; 165():63-89. PubMed ID: 36208907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson's and Alzheimer's Disease.
    Rai SN; Tiwari N; Singh P; Singh AK; Mishra D; Imran M; Singh S; Hooshmandi E; Vamanu E; Singh SK; Singh MP
    Oxid Med Cell Longev; 2022; 2022():3012778. PubMed ID: 36092161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.
    Conte C
    Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 and Parkinson's Disease: A Review of Where We Are Now.
    Boura I; Qamar MA; Daddoveri F; Leta V; Poplawska-Domaszewicz K; Falup-Pecurariu C; Ray Chaudhuri K
    Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-COVID-19 Parkinsonism and Parkinson's Disease Pathogenesis: The Exosomal Cargo Hypothesis.
    Mysiris DS; Vavougios GD; Karamichali E; Papoutsopoulou S; Stavrou VT; Papayianni E; Boutlas S; Mavridis T; Foka P; Zarogiannis SG; Gourgoulianis K; Xiromerisiou G
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating neurological symptoms of infectious diseases like COVID-19 leading to a deeper understanding of neurodegenerative disorders such as Parkinson's disease.
    Zhang J
    Front Neurol; 2022; 13():968193. PubMed ID: 36570463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson's Disease: An Updated Systematic Review.
    Jaiswal V; Alquraish D; Sarfraz Z; Sarfraz A; Nagpal S; Singh Shrestha P; Mukherjee D; Guntipalli P; Sánchez Velazco DF; Bhatnagar A; Savani S; Halilaj E; Ruxmohan S; Cueva W
    J Prim Care Community Health; 2021; 12():21501327211039709. PubMed ID: 34404266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covid-19 Infection and Parkinsonism: Is There a Link?
    Bouali-Benazzouz R; Benazzouz A
    Mov Disord; 2021 Aug; 36(8):1737-1743. PubMed ID: 34080714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Post COVID-19 disorders: is the epidemic of parkinsonism threatening the world?].
    Damulin IV; Strutzenko AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(9):22-28. PubMed ID: 36168684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's Disease and the COVID-19 Pandemic.
    Fearon C; Fasano A
    J Parkinsons Dis; 2021; 11(2):431-444. PubMed ID: 33492244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson's Disease: A Narrative Review.
    Morowitz JM; Pogson KB; Roque DA; Church FC
    Brain Sci; 2022 Apr; 12(5):. PubMed ID: 35624923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Back to the future: lessons from past viral infections and the link with Parkinson's disease.
    Dowd E; McKernan DP
    Neuronal Signal; 2021 Apr; 5(1):NS20200051. PubMed ID: 33953960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covid-19 and Parkinson's disease: an overview.
    Cartella SM; Terranova C; Rizzo V; Quartarone A; Girlanda P
    J Neurol; 2021 Dec; 268(12):4415-4421. PubMed ID: 34313818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viruses, parkinsonism and Parkinson's disease: the past, present and future.
    Leta V; Urso D; Batzu L; Lau YH; Mathew D; Boura I; Raeder V; Falup-Pecurariu C; van Wamelen D; Ray Chaudhuri K
    J Neural Transm (Vienna); 2022 Sep; 129(9):1119-1132. PubMed ID: 36036863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far.
    Boura I; Chaudhuri KR
    Mov Disord Clin Pract; 2022 Jul; 9(5):584-593. PubMed ID: 35601258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms.
    Huang P; Zhang LY; Tan YY; Chen SD
    Transl Neurodegener; 2023 Jan; 12(1):5. PubMed ID: 36717892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexplained worsening of parkinsonian symptoms in a patient with advanced Parkinson's disease as the sole initial presentation of COVID-19 infection: a case report.
    Kamel WA; Ismail II; Ibrahim M; Al-Hashel JY
    Egypt J Neurol Psychiatr Neurosurg; 2021; 57(1):60. PubMed ID: 34025113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's Disease and the COVID-19 Pandemic: A Review Article on the Association between SARS-CoV-2 and α-Synucleinopathy.
    Sinha S; Mittal S; Roy R
    J Mov Disord; 2021 Sep; 14(3):184-192. PubMed ID: 34315206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.